These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26369687)
1. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use. Iijima K; Shimosegawa T Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687 [TBL] [Abstract][Full Text] [Related]
2. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. Iwamoto J; Saito Y; Honda A; Matsuzaki Y World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156 [TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Pilotto A; Franceschi M; Longoa MG; Scarcelli C; Orsitto G; Perri FC; D'Ambrosio LP; Leandro G Dig Liver Dis; 2004 Oct; 36(10):666-70. PubMed ID: 15506665 [TBL] [Abstract][Full Text] [Related]
5. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice. Leung Ki EL; Chan FK Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for gastrointestinal bleeding associated with low-dose aspirin. Valkhoff VE; Sturkenboom MC; Kuipers EJ Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151 [TBL] [Abstract][Full Text] [Related]
7. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y; J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512 [TBL] [Abstract][Full Text] [Related]
8. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents]. Bretagne JF Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327 [TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Lanas A; Scheiman J Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477 [TBL] [Abstract][Full Text] [Related]
10. [Prevention of gastroduodenal complications in patients taking low-dose aspirin]. Chryssostalis A; Marck G; Sibilia J; Chaussade S Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C84-9. PubMed ID: 15366679 [TBL] [Abstract][Full Text] [Related]
11. [Digestive complications of aspirin]. Hochain P; Capet C; Colin R Rev Med Interne; 2000 Mar; 21 Suppl 1():50s-59s. PubMed ID: 10763205 [TBL] [Abstract][Full Text] [Related]
12. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. Lanas A; Gargallo CJ J Gastroenterol; 2015 Jun; 50(6):626-37. PubMed ID: 25595209 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent]. Ahn JY Korean J Gastroenterol; 2020 Nov; 76(5):238-241. PubMed ID: 33234770 [TBL] [Abstract][Full Text] [Related]
15. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
16. [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. Schneider AR; Armbruster S; Mann J; von Römer W; Schuster T; Schepp W Z Gastroenterol; 2012 Nov; 50(11):1156-60. PubMed ID: 23150107 [TBL] [Abstract][Full Text] [Related]
17. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510 [TBL] [Abstract][Full Text] [Related]
18. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors. Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196 [TBL] [Abstract][Full Text] [Related]
19. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. Papatheodoridis GV; Archimandritis AJ World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274 [TBL] [Abstract][Full Text] [Related]
20. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. Hsu PI J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]